spacer

GO Term History: Displaying 185 audit records for all terms for the date 2004-01-03

From (YYYY-MM-DD):
To (YYYY-MM-DD):
Period:
Category:
Terms:
Limit:
Date Specification

You can specify an explicit date range that you are interested in by setting the "From" and "To" parameters; this will limit the data displayed to those changes that were recorded within that (inclusive) date range.

Alternatively, you can use the "Period" parameter to view the GO term changes that occurred over a specific number of Day(s), Week(s), Month(s) or Year(s) before a specified date.

If you do not enter a "To" date, then the period will be relative to the current date. If, however, you do specify a "To" value, then the "Period" value will display records in the timeframe up to and including that specified date.

Category

You can use this field to specify what types of term changes you are interested in seeing.

Terms

You can enter a list of GO Terms in this field to limit the changes displayed. Please note that only changes made to directly listed terms will be displayed, not term descendants.

Limit

The default number of records returned is 500, however you can increase or decrease this limit. In order to prevent possible browser problems, the maximum upper limit is 10,000.

Introduction

This page displays the differences recorded in the full Gene Ontology OBO v1.2 file as audited by the UniProt-GOA database during its daily update cycle.
If there is any delay in uploading the current OBO file, the changes displayed and the date recorded for these changes may not correspond to when the changes to the OBO file were committed.

All changes

Timestamp GO ID GO Term Name Action Category Detail
2004-01-03 GO:0048168 regulation of neuronal synaptic plasticity Updated DEFINITION A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2004-01-03 GO:0048172 regulation of short-term neuronal synaptic plasticity Updated DEFINITION A process that modulates short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
2004-01-03 GO:0048167 regulation of synaptic plasticity Updated DEFINITION A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2004-01-03 GO:0003708 retinoic acid receptor activity Updated DEFINITION Combining with retinoic acid to initiate a change in cell activity.
2004-01-03 GO:0004993 serotonin receptor activity Updated DEFINITION Combining with the biogenic amine serotonin, a neurotransmitter and hormone found in vertebrates, invertebrates and plants, to initiate a change in cell activity.
2004-01-03 GO:0004994 somatostatin receptor activity Updated DEFINITION Combining with somatostatin to initiate a change in cell activity.
2004-01-03 GO:0005020 stem cell factor receptor activity Updated DEFINITION Combining with stem cell factor, a cytokine that stimulates mast cell growth and differentiation, to initiate a change in cell activity.
2004-01-03 GO:0003707 steroid hormone receptor activity Updated DEFINITION Combining with a steroid hormone to initiate a change in cell activity.
2004-01-03 GO:0008281 sulfonylurea receptor activity Updated DEFINITION Combining with sulfonylurea to initiate a change in cell activity.
2004-01-03 GO:0004995 tachykinin receptor activity Updated DEFINITION Combining with tachykinin to initiate a change in cell activity.
2004-01-03 GO:0008527 taste receptor activity Updated DEFINITION Combining with soluble compounds to initiate a change in cell activity. These receptors are responsible for the sense of taste.
2004-01-03 GO:0015057 thrombin receptor activity Updated DEFINITION Combining with thrombin to initiate a change in cell activity.
2004-01-03 GO:0004887 thyroid hormone receptor activity Updated DEFINITION Combining with thyroid hormone to initiate a change in cell activity.
2004-01-03 GO:0008226 tyramine receptor activity Updated DEFINITION Combining with the biogenic amine tyramine to initiate a change in cell activity. Tyramine is a sympathomimetic amine derived from tyrosine with an action resembling that of epinephrine.
2004-01-03 GO:0015065 uridine nucleotide receptor activity Updated DEFINITION Combining with UTP or UDP to initiate a change in cell activity.
2004-01-03 GO:0005000 vasopressin receptor activity Updated DEFINITION Combining with vasopressin to initiate a change in cell activity.
2004-01-03 GO:0030229 very-low-density lipoprotein particle receptor activity Updated DEFINITION Combining with a very-low-density lipoprotein to initiate a change in cell activity.
2004-01-03 GO:0001618 virus receptor activity Updated DEFINITION Combining with a virus component to initiate a change in cell activity.
2004-01-03 GO:0008434 calcitriol receptor activity Updated DEFINITION Combining with vitamin D3 to initiate a change in cell activity.
2004-01-03 GO:0008196 vitellogenin receptor activity Updated DEFINITION Combining with vitellogenin to initiate a change in cell activity.
2004-01-03 GO:0042813 Wnt-activated receptor activity Updated DEFINITION Combining with a member of the Wnt-family of signaling molecules to initiate a change in cell activity.
2004-01-03 GO:0008066 glutamate receptor activity Updated DEFINITION Combining with glutamate to initiate a change in cell activity.
2004-01-03 GO:0004902 granulocyte colony-stimulating factor receptor activity Updated DEFINITION Combining with granulocyte colony-stimulating factor to initiate a change in cell activity.
2004-01-03 GO:0004901 granulocyte macrophage colony-stimulating factor receptor activity Updated DEFINITION Combining with granulocyte macrophage colony-stimulating factor to initiate a change in cell activity.
2004-01-03 GO:0004903 growth hormone receptor activity Updated DEFINITION Combining with growth hormone to initiate a change in cell activity.
2004-01-03 GO:0016520 growth hormone-releasing hormone receptor activity Updated DEFINITION Combining with growth hormone-releasing hormone to initiate a change in cell activity.
2004-01-03 GO:0008158 hedgehog receptor activity Updated DEFINITION Combining with the hedgehog protein to initiate a change in cell activity.
2004-01-03 GO:0030373 high molecular weight B cell growth factor receptor activity Updated DEFINITION Combining with a high molecular weight B-cell growth factor to initiate a change in cell activity.
2004-01-03 GO:0004969 histamine receptor activity Updated DEFINITION Combining with histamine to initiate a change in cell activity. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans.
2004-01-03 GO:0030369 ICAM-3 receptor activity Updated DEFINITION Combining with ICAM-3, intercellular adhesion molecule 3, to initiate a change in cell activity. ICAM-3, or CD50, are constitutively expressed on monocytes, granulocytes and lymphocytes; on physiological stimulation, they become transiently phosphorylated on serine residues.
2004-01-03 GO:0004953 icosanoid receptor activity Updated DEFINITION Combining with an icosanoid to initiate a change in cell activity.
2004-01-03 GO:0008095 inositol-1,4,5-trisphosphate receptor activity Updated DEFINITION Combining with inositol-1,4,5-triphosphate to initiate a change in cell activity.
2004-01-03 GO:0005009 insulin-activated receptor activity Updated DEFINITION Combining with insulin to initiate a change in cell activity.
2004-01-03 GO:0004904 interferon receptor activity Updated DEFINITION Combining with an interferon to initiate a change in cell activity.
2004-01-03 GO:0004906 interferon-gamma receptor activity Updated DEFINITION Combining with interferon-gamma to initiate a change in cell activity.
2004-01-03 GO:0004907 interleukin receptor activity Updated DEFINITION Combining with an interleukin to initiate a change in cell activity.
2004-01-03 GO:0004908 interleukin-1 receptor activity Updated DEFINITION Combining with interleukin-1 to initiate a change in cell activity. Interleukin-1 is produced mainly by activated macrophages and is involved in the inflammatory response.
2004-01-03 GO:0004920 interleukin-10 receptor activity Updated DEFINITION Combining with interleukin-10 to initiate a change in cell activity.
2004-01-03 GO:0004921 interleukin-11 receptor activity Updated DEFINITION Combining with interleukin-11 to initiate a change in cell activity.
2004-01-03 GO:0016517 interleukin-12 receptor activity Updated DEFINITION Combining with interleukin-12 to initiate a change in cell activity.
2004-01-03 GO:0016515 interleukin-13 receptor activity Updated DEFINITION Combining with interleukin-13 to initiate a change in cell activity.
2004-01-03 GO:0016518 interleukin-14 receptor activity Updated DEFINITION Combining with interleukin-14 to initiate a change in cell activity.
2004-01-03 GO:0030278 regulation of ossification Added SYNONYM regulation of bone formation
2004-01-03 GO:0030279 negative regulation of ossification Added SYNONYM negative regulation of bone formation
2004-01-03 GO:0030503 regulation of cell redox homeostasis Added SYNONYM regulation of redox homeostasis
2004-01-03 GO:0042103 positive regulation of T cell homeostatic proliferation Added SYNONYM positive regulation of resting T-cell proliferation
2004-01-03 GO:0050691 regulation of defense response to virus by host Added SYNONYM host regulation of antiviral response
2004-01-03 GO:0042348 NF-kappaB import into nucleus Added SYNONYM NF-kappaB protein-nucleus import
2004-01-03 GO:0045778 positive regulation of ossification Added SYNONYM positive regulation of bone formation
2004-01-03 GO:0046013 regulation of T cell homeostatic proliferation Added SYNONYM regulation of resting T-cell proliferation
2004-01-03 GO:0019052 suppression by virus of host intracellular antiviral response Deleted SYNONYM negative regulation by virus of intracellular antiviral response
2004-01-03 GO:0019053 suppression by virus of host extracellular antiviral response Deleted SYNONYM negative regulation by virus of extracellular antiviral response
2004-01-03 GO:0001777 T cell homeostatic proliferation Added SYNONYM resting T-cell proliferation
2004-01-03 GO:0019052 suppression by virus of host intracellular antiviral response Added SYNONYM viral inhibition of intracellular antiviral response
2004-01-03 GO:0019053 suppression by virus of host extracellular antiviral response Added SYNONYM inhibition of extracellular antiviral response
2004-01-03 GO:0046014 negative regulation of T cell homeostatic proliferation Added SYNONYM negative regulation of resting T-cell proliferation
2004-01-03 GO:0050690 regulation of defense response to virus by virus Added SYNONYM viral regulation of antiviral response
2004-01-03 GO:0008261 allatostatin receptor activity Updated DEFINITION Combining with allatostatin to initiate a change in cell activity.
2004-01-03 GO:0016964 alpha-2 macroglobulin receptor activity Updated DEFINITION Combining with an alpha-2 macroglobulin to initiate a change in cell activity.
2004-01-03 GO:0008227 G-protein coupled amine receptor activity Updated DEFINITION Combining with a biogenic amine to initiate a change in cell activity.
2004-01-03 GO:0004942 anaphylatoxin receptor activity Updated DEFINITION Combining with anaphylatoxin to initiate a change in cell activity.
2004-01-03 GO:0004882 androgen receptor activity Updated DEFINITION Combining with an androgen to initiate a change in cell activity.
2004-01-03 GO:0001595 angiotensin receptor activity Updated DEFINITION Combining with angiotensin to initiate a change in cell activity.
2004-01-03 GO:0030895 apolipoprotein B mRNA editing enzyme complex Updated DEFINITION Protein complex that mediates editing of the mRNA encoding apolipoprotein B; catalyzes the deamination of C to U (residue 6666 in the human mRNA). Contains a catalytic subunit, APOBEC-1, and other proteins (e. g. human ASP; rat ASP and KSRP).
2004-01-03 GO:0030227 apolipoprotein E receptor activity Updated DEFINITION Combining with apolipoprotein E to initiate a change in cell activity.
2004-01-03 GO:0030226 apolipoprotein receptor activity Updated DEFINITION Combining with an apolipoprotein, the protein component of a lipoprotein, to initiate a change in cell activity.
2004-01-03 GO:0004874 aryl hydrocarbon receptor activity Updated DEFINITION Combining with an aryl hydrocarbon to initiate a change in cell activity.
2004-01-03 GO:0043057 backward locomotion Updated DEFINITION Posterior movement of an organism, e. g., following the direction of the tail of an animal.
2004-01-03 GO:0008503 benzodiazepine receptor activity Updated DEFINITION Combining with benzodiazepines, a class of drugs with hypnotic, anxiolytic, anticonvulsive, amnestic and myorelaxant properties, to initiate a change in cell activity.
2004-01-03 GO:0004979 beta-endorphin receptor activity Updated DEFINITION Combining with beta-endorphin to initiate a change in cell activity.
2004-01-03 GO:0004946 bombesin receptor activity Updated DEFINITION Combining with bombesin to initiate a change in cell activity.
2004-01-03 GO:0008288 boss receptor activity Updated DEFINITION Combining with the protein bride of sevenless (boss) to initiate a change in cell activity.
2004-01-03 GO:0004947 bradykinin receptor activity Updated DEFINITION Combining with bradykinin to initiate a change in cell activity.
2004-01-03 GO:0016493 C-C chemokine receptor activity Updated DEFINITION Combining with a C-C chemokine to initiate a change in cell activity. C-C chemokines do not have an amino acid between the first two cysteines of the characteristic four-cysteine motif.
2004-01-03 GO:0016494 C-X-C chemokine receptor activity Updated DEFINITION Combining with a C-X-C chemokine to initiate a change in cell activity. A C-X-C chemokine has a single amino acid between the first two cysteines of the characteristic four cysteine motif.
2004-01-03 GO:0016495 C-X3-C chemokine receptor activity Updated DEFINITION Combining with a C-X3-C chemokine to initiate a change in cell activity. A C-X3-C chemokine has three amino acids between the first two cysteines of the characteristic four-cysteine motif.
2004-01-03 GO:0042010 interleukin-15 receptor activity Updated DEFINITION Combining with interleukin-15 to initiate a change in cell activity.
2004-01-03 GO:0042012 interleukin-16 receptor activity Updated DEFINITION Combining with interleukin-16 to initiate a change in cell activity.
2004-01-03 GO:0030368 interleukin-17 receptor activity Updated DEFINITION Combining with interleukin-17 to initiate a change in cell activity.
2004-01-03 GO:0042008 interleukin-18 receptor activity Updated DEFINITION Combining with interleukin-18 to initiate a change in cell activity.
2004-01-03 GO:0042014 interleukin-19 receptor activity Updated DEFINITION Combining with interleukin-19 to initiate a change in cell activity.
2004-01-03 GO:0004911 interleukin-2 receptor activity Updated DEFINITION Combining with interleukin-2 to initiate a change in cell activity.
2004-01-03 GO:0042016 interleukin-20 receptor activity Updated DEFINITION Combining with interleukin-20 to initiate a change in cell activity.
2004-01-03 GO:0001532 interleukin-21 receptor activity Updated DEFINITION Combining with interleukin-21 to initiate a change in cell activity.
2004-01-03 GO:0042018 interleukin-22 receptor activity Updated DEFINITION Combining with interleukin-22 to initiate a change in cell activity.
2004-01-03 GO:0042020 interleukin-23 receptor activity Updated DEFINITION Combining with interleukin-23 to initiate a change in cell activity.
2004-01-03 GO:0045506 interleukin-24 receptor activity Updated DEFINITION Combining with interleukin-24 to initiate a change in cell activity.
2004-01-03 GO:0045507 interleukin-25 receptor activity Updated DEFINITION Combining with interleukin-25 to initiate a change in cell activity.
2004-01-03 GO:0045508 interleukin-26 receptor activity Updated DEFINITION Combining with interleukin-26 to initiate a change in cell activity.
2004-01-03 GO:0045509 interleukin-27 receptor activity Updated DEFINITION Combining with interleukin-27 to initiate a change in cell activity.
2004-01-03 GO:0004985 opioid receptor activity Updated DEFINITION Combining with an opioid, any narcotic derived from or resembling opium, to initiate a change in cell activity.
2004-01-03 GO:0016499 orexin receptor activity Updated DEFINITION Combining with orexin to initiate a change in cell activity.
2004-01-03 GO:0004990 oxytocin receptor activity Updated DEFINITION Combining with oxytocin to initiate a change in cell activity.
2004-01-03 GO:0001602 pancreatic polypeptide receptor activity Updated DEFINITION Combining with pancreatic polypeptide PP to initiate a change in cell activity.
2004-01-03 GO:0001653 peptide receptor activity Updated DEFINITION Combining with an extracellular or intracellular peptide to initiate a change in cell activity.
2004-01-03 GO:0001601 peptide YY receptor activity Updated DEFINITION Combining with gut peptide YY to initiate a change in cell activity.
2004-01-03 GO:0016503 pheromone receptor activity Updated DEFINITION Combining with a pheromone to initiate a change in cell activity.
2004-01-03 GO:0001565 phorbol ester receptor activity Updated DEFINITION Combining with a phorbol ester to initiate a change in cell activity.
2004-01-03 GO:0048170 positive regulation of long-term neuronal synaptic plasticity Updated DEFINITION A process that increases long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
2004-01-03 GO:0048173 positive regulation of short-term neuronal synaptic plasticity Updated DEFINITION A process that increases short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
2004-01-03 GO:0001785 prostaglandin J receptor activity Updated DEFINITION The function of combining with prostaglandin J (PGJ(2)), a metabolite of prostaglandin D (PGD(2)) to initiate a change in cell activity.
2004-01-03 GO:0004872 receptor activity Updated DEFINITION Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
2004-01-03 GO:0015056 corticotrophin-releasing factor receptor activity Updated DEFINITION Combining with the corticotrophin-releasing factor family of ligands, including the urocortins, to initiate a change in cell activity.
2004-01-03 GO:0001631 cysteinyl leukotriene receptor activity Updated DEFINITION Combining with a cysteinyl leukotriene to initiate a change in cell activity. Cysteinyl leukotrienes are leukotrienes that contain a peptide moiety based on cysteine.
2004-01-03 GO:0009884 cytokinin receptor activity Updated DEFINITION Combining with a cytokinin to initiate a change in cell activity.
2004-01-03 GO:0008036 diuretic hormone receptor activity Updated DEFINITION Combining with a diuretic hormone to initiate a change in cell activity.
2004-01-03 GO:0004952 dopamine neurotransmitter receptor activity Updated DEFINITION Combining with the neurotransmitter dopamine to initiate a change in cell activity.
2004-01-03 GO:0042654 ecdysis-triggering hormone receptor activity Updated DEFINITION Combining with ecdysis-triggering hormone to initiate a change in cell activity.
2004-01-03 GO:0004884 ecdysteroid hormone receptor activity Updated DEFINITION Combining with ecdysteroid hormone to initiate a change in cell activity.
2004-01-03 GO:0008529 endogenous peptide receptor activity Updated DEFINITION OBSOLETE. Combining with an intracellular peptide to initiate a change in cell activity.
2004-01-03 GO:0004962 endothelin receptor activity Updated DEFINITION Combining with endothelin to initiate a change in cell activity.
2004-01-03 GO:0004900 erythropoietin receptor activity Updated DEFINITION Combining with erythropoietin to initiate a change in cell activity.
2004-01-03 GO:0030284 estrogen receptor activity Updated DEFINITION Combining with estrogen to initiate a change in cell activity.
2004-01-03 GO:0008530 exogenous peptide receptor activity Updated DEFINITION OBSOLETE. Combining with an extracellular peptide to initiate a change in cell activity.
2004-01-03 GO:0019763 immunoglobulin receptor activity Updated DEFINITION Combining with the Fc region of an immunoglobulin protein to initiate a change in cell activity.
2004-01-03 GO:0004928 frizzled receptor activity Updated DEFINITION OBSOLETE. Combining with a member of the Wnt-family of signaling molecules to initiate a change in cell activity.
2004-01-03 GO:0004929 frizzled-2 receptor activity Updated DEFINITION OBSOLETE. Combining with to a member of the Wnt-family of signaling molecules to initiate a change in cell activity.
2004-01-03 GO:0001647 G-protein coupled cytokinin receptor activity Updated DEFINITION Combining with a cytokinin to initiate a change in cell activity. The receptor is G-protein coupled.
2004-01-03 GO:0016917 GABA receptor activity Updated DEFINITION Combining with the neurotransmitter GABA (gamma aminobutyric acid) to initiate a change in cell activity.
2004-01-03 GO:0004890 GABA-A receptor activity Updated DEFINITION Combining with the neurotransmitter GABA-A (gamma aminobutyric acid) to initiate a change in cell activity.
2004-01-03 GO:0048169 regulation of long-term neuronal synaptic plasticity Updated DEFINITION A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
2004-01-03 GO:0030278 regulation of ossification Updated TERM regulation of ossification
2004-01-03 GO:0030279 negative regulation of ossification Updated TERM negative regulation of ossification
2004-01-03 GO:0030503 regulation of cell redox homeostasis Updated TERM regulation of cell redox homeostasis
2004-01-03 GO:0019052 suppression by virus of host intracellular antiviral response Updated TERM negative regulation by virus of intracellular antiviral response
2004-01-03 GO:0019053 suppression by virus of host extracellular antiviral response Updated TERM negative regulation by virus of extracellular antiviral response
2004-01-03 GO:0046013 regulation of T cell homeostatic proliferation Updated TERM regulation of T-cell homeostatic proliferation
2004-01-03 GO:0046014 negative regulation of T cell homeostatic proliferation Updated TERM negative regulation of T-cell homeostatic proliferation
2004-01-03 GO:0042348 NF-kappaB import into nucleus Updated TERM NF-kappaB-nucleus import
2004-01-03 GO:0042103 positive regulation of T cell homeostatic proliferation Updated TERM positive regulation of T-cell homeostatic proliferation
2004-01-03 GO:0050798 activated T cell proliferation Added TERM activated T-cell proliferation
2004-01-03 GO:0050799 cocaine biosynthetic process Added TERM cocaine biosynthesis
2004-01-03 GO:0045778 positive regulation of ossification Updated TERM positive regulation of ossification
2004-01-03 GO:0050690 regulation of defense response to virus by virus Updated TERM regulation by virus of antiviral response
2004-01-03 GO:0050691 regulation of defense response to virus by host Updated TERM regulation by host of antiviral response
2004-01-03 GO:0004949 cannabinoid receptor activity Updated DEFINITION Combining with cannabinoids to initiate a change in cell activity.
2004-01-03 GO:0004895 cell adhesion receptor activity Updated DEFINITION Combining with cell adhesion molecules to initiate a change in cell activity.
2004-01-03 GO:0030896 checkpoint clamp complex Updated DEFINITION Conserved heterotrimeric complex of PCNA-like proteins that is loaded onto DNA at sites of DNA damage.
2004-01-03 GO:0004950 chemokine receptor activity Updated DEFINITION Combining with chemokines, small chemoattractant molecules normally used to stimulate leukocytes, to initiate a change in cell activity.
2004-01-03 GO:0004951 cholecystokinin receptor activity Updated DEFINITION Combining with cholecystokinin, a 33-amino acid peptide secreted by the upper intestinal mucosa and also found in the central nervous system, to initiate a change in cell activity.
2004-01-03 GO:0050799 cocaine biosynthetic process Added DEFINITION The formation from simpler components of cocaine, an alkaloid obtained from the dried leaves of the shrub Erythroxylon coca. It is a cerebral stimulant and narcotic.
2004-01-03 GO:0004965 G-protein coupled GABA receptor activity Updated DEFINITION Combining with the neurotransmitter GABA-B (gamma aminobutyric acid) to initiate a change in cell activity.
2004-01-03 GO:0004966 galanin receptor activity Updated DEFINITION Combining with galanin to initiate a change in cell activity.
2004-01-03 GO:0016519 gastric inhibitory peptide receptor activity Updated DEFINITION Combining with gastric inhibitory peptide to initiate a change in cell activity.
2004-01-03 GO:0015054 gastrin receptor activity Updated DEFINITION Combining with gastrin to initiate a change in cell activity.
2004-01-03 GO:0004883 glucocorticoid receptor activity Updated DEFINITION Combining with a glucocorticoid to initiate a change in cell activity.
2004-01-03 GO:0004912 interleukin-3 receptor activity Updated DEFINITION Combining with interleukin-3 to initiate a change in cell activity.
2004-01-03 GO:0004913 interleukin-4 receptor activity Updated DEFINITION Combining with interleukin-4 to initiate a change in cell activity.
2004-01-03 GO:0004914 interleukin-5 receptor activity Updated DEFINITION Combining with interleukin-5 to initiate a change in cell activity.
2004-01-03 GO:0004915 interleukin-6 receptor activity Updated DEFINITION Combining with interleukin-6 to initiate a change in cell activity.
2004-01-03 GO:0004917 interleukin-7 receptor activity Updated DEFINITION Combining with interleukin-7 to initiate a change in cell activity.
2004-01-03 GO:0004918 interleukin-8 receptor activity Updated DEFINITION Combining with interleukin-8 to initiate a change in cell activity.
2004-01-03 GO:0004919 interleukin-9 receptor activity Updated DEFINITION Combining with interleukin-9 to initiate a change in cell activity.
2004-01-03 GO:0004880 juvenile hormone receptor activity Updated DEFINITION Combining with juvenile hormone to initiate a change in cell activity.
2004-01-03 GO:0005055 laminin receptor activity Updated DEFINITION Combining with a laminin, a glycoprotein that constitutes the majority of proteins in the basement membrane, to initiate a change in cell activity.
2004-01-03 GO:0016524 latrotoxin receptor activity Updated DEFINITION Combining with alpha-latrotoxin, a potent presynaptic neurotoxin, to initiate a change in cell activity.
2004-01-03 GO:0001632 leukotriene B4 receptor activity Updated DEFINITION Combining with leukotriene B4, LTB4, to initiate a change in cell activity. Leukotriene B4 is also known as (6Z, 8E, 10E, 14Z)-(5S, 12R)-5,12-dihydroxyicosa-6,8,10,14-tetraen-1-oate.
2004-01-03 GO:0004974 leukotriene receptor activity Updated DEFINITION Combining with a leukotriene to initiate a change in cell activity. Leukotrienes are pharmacologically active substances with a set of three conjugated double bonds; some contain a peptide moiety based on cysteine.
2004-01-03 GO:0030228 lipoprotein particle receptor activity Updated DEFINITION Combining with a lipoprotein to initiate a change in cell activity. A lipoprotein is any conjugated, water-soluble protein in which the nonprotein moiety consists of a lipid or lipids; the lipid may be triacylglycerol, cholesterol, or phospholipid, or a combination of these.
2004-01-03 GO:0005041 low-density lipoprotein receptor activity Updated DEFINITION Combining with a low-density lipoprotein to initiate a change in cell activity.
2004-01-03 GO:0001619 lysosphingolipid and lysophosphatidic acid receptor activity Updated DEFINITION Combining with lysosphingolipid or lysophosphatidic acid to initiate a change in cell activity.
2004-01-03 GO:0005011 macrophage colony-stimulating factor receptor activity Updated DEFINITION Combining with macrophage colony stimulating factor to initiate a change in cell activity.
2004-01-03 GO:0004932 mating-type factor pheromone receptor activity Updated DEFINITION Combining with a mating-type factor pheromone to initiate a change in cell activity.
2004-01-03 GO:0030273 melanin-concentrating hormone receptor activity Updated DEFINITION Combining with the cyclic peptide hormone melanin-concentrating hormone to initiate a change in cell activity.
2004-01-03 GO:0004977 melanocortin receptor activity Updated DEFINITION Combining with melanocortin to initiate a change in cell activity.
2004-01-03 GO:0008502 melatonin receptor activity Updated DEFINITION Combining with melatonin, N-acetyl-5-methoxytryptamine, to initiate a change in cell activity. Melatonin is a neuroendocrine substance that stimulates the aggregation of melanosomes in melanophores, thus lightening the skin.
2004-01-03 GO:0017082 mineralocorticoid receptor activity Updated DEFINITION Combining with mineralocorticoid to initiate a change in cell activity.
2004-01-03 GO:0035013 myosuppressin receptor activity Updated DEFINITION Combining with the peptide myosuppressin to initiate a change in cell activity.
2004-01-03 GO:0004982 N-formyl peptide receptor activity Updated DEFINITION Combining with an N-formyl peptide to initiate a change in cell activity.
2004-01-03 GO:0048171 negative regulation of long-term neuronal synaptic plasticity Updated DEFINITION A process that decreases long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
2004-01-03 GO:0048174 negative regulation of short-term neuronal synaptic plasticity Updated DEFINITION A process that decreases short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
2004-01-03 GO:0001607 neuromedin U receptor activity Updated DEFINITION Combining with neuromedin U to initiate a change in cell activity.
2004-01-03 GO:0042263 neuropeptide F receptor activity Updated DEFINITION Combining with neuropeptide F, an invertebrate neuropeptide thought to play a role in neuroregulation, to initiate a change in cell activity. In many species, neuropeptide F is between 36 and 39 amino acid residues terminating in a phenylalaninamide residue.
2004-01-03 GO:0008188 neuropeptide receptor activity Updated DEFINITION Combining with a neuropeptide to initiate a change in cell activity.
2004-01-03 GO:0004983 neuropeptide Y receptor activity Updated DEFINITION Combining with neuropeptide Y to initiate a change in cell activity.
2004-01-03 GO:0030594 neurotransmitter receptor activity Updated DEFINITION Combining with a neurotransmitter to initiate a change in cell activity.
2004-01-03 GO:0005049 nuclear export signal receptor activity Updated DEFINITION Combining with a nuclear export signal to initiate a change in cell activity.
2004-01-03 GO:0016502 nucleotide receptor activity Updated DEFINITION Combining with a nucleotide to initiate a change in cell activity. A nucleotide is a compound that consists of a nucleoside esterified with a phosphate molecule.
2004-01-03 GO:0004989 octopamine receptor activity Updated DEFINITION Combining with the biogenic amine octopamine to initiate a change in cell activity. Octopamine is found in both vertebrates and invertebrates and can have properties both of a hormone and a neurotransmitter and acts as an adrenergic agonist.
2004-01-03 GO:0004984 olfactory receptor activity Updated DEFINITION Combining with airborne compounds to initiate a change in cell activity. These receptors are used for the sense of smell.
2004-01-03 GO:0015464 acetylcholine receptor activity Updated DEFINITION Combining with acetylcholine to initiate a change in cell activity.
2004-01-03 GO:0050798 activated T cell proliferation Added DEFINITION The rapid expansion of a T-cell population following activation by an antigenic stimulus.
2004-01-03 GO:0004978 corticotropin receptor activity Updated DEFINITION Combining with adrenocorticotropin to initiate a change in cell activity.
2004-01-03 GO:0001605 adrenomedullin receptor activity Updated DEFINITION Combining with adrenomedullin to initiate a change in cell activity.
2004-01-03 GO:0050785 advanced glycation end-product receptor activity Updated DEFINITION Combining with advanced glycation end-products to initiate a change in cell activity.

Terms

Timestamp GO ID GO Term Name Action Category Detail
2004-01-03 GO:0030278 regulation of ossification Updated TERM regulation of ossification
2004-01-03 GO:0030279 negative regulation of ossification Updated TERM negative regulation of ossification
2004-01-03 GO:0030503 regulation of cell redox homeostasis Updated TERM regulation of cell redox homeostasis
2004-01-03 GO:0019052 suppression by virus of host intracellular antiviral response Updated TERM negative regulation by virus of intracellular antiviral response
2004-01-03 GO:0019053 suppression by virus of host extracellular antiviral response Updated TERM negative regulation by virus of extracellular antiviral response
2004-01-03 GO:0046013 regulation of T cell homeostatic proliferation Updated TERM regulation of T-cell homeostatic proliferation
2004-01-03 GO:0046014 negative regulation of T cell homeostatic proliferation Updated TERM negative regulation of T-cell homeostatic proliferation
2004-01-03 GO:0042348 NF-kappaB import into nucleus Updated TERM NF-kappaB-nucleus import
2004-01-03 GO:0042103 positive regulation of T cell homeostatic proliferation Updated TERM positive regulation of T-cell homeostatic proliferation
2004-01-03 GO:0050798 activated T cell proliferation Added TERM activated T-cell proliferation
2004-01-03 GO:0050799 cocaine biosynthetic process Added TERM cocaine biosynthesis
2004-01-03 GO:0045778 positive regulation of ossification Updated TERM positive regulation of ossification
2004-01-03 GO:0050690 regulation of defense response to virus by virus Updated TERM regulation by virus of antiviral response
2004-01-03 GO:0050691 regulation of defense response to virus by host Updated TERM regulation by host of antiviral response

Definition/synonyms

Timestamp GO ID GO Term Name Action Category Detail
2004-01-03 GO:0048168 regulation of neuronal synaptic plasticity Updated DEFINITION A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2004-01-03 GO:0048172 regulation of short-term neuronal synaptic plasticity Updated DEFINITION A process that modulates short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
2004-01-03 GO:0048167 regulation of synaptic plasticity Updated DEFINITION A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.
2004-01-03 GO:0003708 retinoic acid receptor activity Updated DEFINITION Combining with retinoic acid to initiate a change in cell activity.
2004-01-03 GO:0004993 serotonin receptor activity Updated DEFINITION Combining with the biogenic amine serotonin, a neurotransmitter and hormone found in vertebrates, invertebrates and plants, to initiate a change in cell activity.
2004-01-03 GO:0004994 somatostatin receptor activity Updated DEFINITION Combining with somatostatin to initiate a change in cell activity.
2004-01-03 GO:0005020 stem cell factor receptor activity Updated DEFINITION Combining with stem cell factor, a cytokine that stimulates mast cell growth and differentiation, to initiate a change in cell activity.
2004-01-03 GO:0003707 steroid hormone receptor activity Updated DEFINITION Combining with a steroid hormone to initiate a change in cell activity.
2004-01-03 GO:0008281 sulfonylurea receptor activity Updated DEFINITION Combining with sulfonylurea to initiate a change in cell activity.
2004-01-03 GO:0004995 tachykinin receptor activity Updated DEFINITION Combining with tachykinin to initiate a change in cell activity.
2004-01-03 GO:0008527 taste receptor activity Updated DEFINITION Combining with soluble compounds to initiate a change in cell activity. These receptors are responsible for the sense of taste.
2004-01-03 GO:0015057 thrombin receptor activity Updated DEFINITION Combining with thrombin to initiate a change in cell activity.
2004-01-03 GO:0004887 thyroid hormone receptor activity Updated DEFINITION Combining with thyroid hormone to initiate a change in cell activity.
2004-01-03 GO:0008226 tyramine receptor activity Updated DEFINITION Combining with the biogenic amine tyramine to initiate a change in cell activity. Tyramine is a sympathomimetic amine derived from tyrosine with an action resembling that of epinephrine.
2004-01-03 GO:0015065 uridine nucleotide receptor activity Updated DEFINITION Combining with UTP or UDP to initiate a change in cell activity.
2004-01-03 GO:0005000 vasopressin receptor activity Updated DEFINITION Combining with vasopressin to initiate a change in cell activity.
2004-01-03 GO:0030229 very-low-density lipoprotein particle receptor activity Updated DEFINITION Combining with a very-low-density lipoprotein to initiate a change in cell activity.
2004-01-03 GO:0001618 virus receptor activity Updated DEFINITION Combining with a virus component to initiate a change in cell activity.
2004-01-03 GO:0008434 calcitriol receptor activity Updated DEFINITION Combining with vitamin D3 to initiate a change in cell activity.
2004-01-03 GO:0008196 vitellogenin receptor activity Updated DEFINITION Combining with vitellogenin to initiate a change in cell activity.
2004-01-03 GO:0042813 Wnt-activated receptor activity Updated DEFINITION Combining with a member of the Wnt-family of signaling molecules to initiate a change in cell activity.
2004-01-03 GO:0008066 glutamate receptor activity Updated DEFINITION Combining with glutamate to initiate a change in cell activity.
2004-01-03 GO:0004902 granulocyte colony-stimulating factor receptor activity Updated DEFINITION Combining with granulocyte colony-stimulating factor to initiate a change in cell activity.
2004-01-03 GO:0004901 granulocyte macrophage colony-stimulating factor receptor activity Updated DEFINITION Combining with granulocyte macrophage colony-stimulating factor to initiate a change in cell activity.
2004-01-03 GO:0004903 growth hormone receptor activity Updated DEFINITION Combining with growth hormone to initiate a change in cell activity.
2004-01-03 GO:0016520 growth hormone-releasing hormone receptor activity Updated DEFINITION Combining with growth hormone-releasing hormone to initiate a change in cell activity.
2004-01-03 GO:0008158 hedgehog receptor activity Updated DEFINITION Combining with the hedgehog protein to initiate a change in cell activity.
2004-01-03 GO:0030373 high molecular weight B cell growth factor receptor activity Updated DEFINITION Combining with a high molecular weight B-cell growth factor to initiate a change in cell activity.
2004-01-03 GO:0004969 histamine receptor activity Updated DEFINITION Combining with histamine to initiate a change in cell activity. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans.
2004-01-03 GO:0030369 ICAM-3 receptor activity Updated DEFINITION Combining with ICAM-3, intercellular adhesion molecule 3, to initiate a change in cell activity. ICAM-3, or CD50, are constitutively expressed on monocytes, granulocytes and lymphocytes; on physiological stimulation, they become transiently phosphorylated on serine residues.
2004-01-03 GO:0004953 icosanoid receptor activity Updated DEFINITION Combining with an icosanoid to initiate a change in cell activity.
2004-01-03 GO:0008095 inositol-1,4,5-trisphosphate receptor activity Updated DEFINITION Combining with inositol-1,4,5-triphosphate to initiate a change in cell activity.
2004-01-03 GO:0005009 insulin-activated receptor activity Updated DEFINITION Combining with insulin to initiate a change in cell activity.
2004-01-03 GO:0004904 interferon receptor activity Updated DEFINITION Combining with an interferon to initiate a change in cell activity.
2004-01-03 GO:0004906 interferon-gamma receptor activity Updated DEFINITION Combining with interferon-gamma to initiate a change in cell activity.
2004-01-03 GO:0004907 interleukin receptor activity Updated DEFINITION Combining with an interleukin to initiate a change in cell activity.
2004-01-03 GO:0004908 interleukin-1 receptor activity Updated DEFINITION Combining with interleukin-1 to initiate a change in cell activity. Interleukin-1 is produced mainly by activated macrophages and is involved in the inflammatory response.
2004-01-03 GO:0004920 interleukin-10 receptor activity Updated DEFINITION Combining with interleukin-10 to initiate a change in cell activity.
2004-01-03 GO:0004921 interleukin-11 receptor activity Updated DEFINITION Combining with interleukin-11 to initiate a change in cell activity.
2004-01-03 GO:0016517 interleukin-12 receptor activity Updated DEFINITION Combining with interleukin-12 to initiate a change in cell activity.
2004-01-03 GO:0016515 interleukin-13 receptor activity Updated DEFINITION Combining with interleukin-13 to initiate a change in cell activity.
2004-01-03 GO:0016518 interleukin-14 receptor activity Updated DEFINITION Combining with interleukin-14 to initiate a change in cell activity.
2004-01-03 GO:0030278 regulation of ossification Added SYNONYM regulation of bone formation
2004-01-03 GO:0030279 negative regulation of ossification Added SYNONYM negative regulation of bone formation
2004-01-03 GO:0030503 regulation of cell redox homeostasis Added SYNONYM regulation of redox homeostasis
2004-01-03 GO:0042103 positive regulation of T cell homeostatic proliferation Added SYNONYM positive regulation of resting T-cell proliferation
2004-01-03 GO:0050691 regulation of defense response to virus by host Added SYNONYM host regulation of antiviral response
2004-01-03 GO:0042348 NF-kappaB import into nucleus Added SYNONYM NF-kappaB protein-nucleus import
2004-01-03 GO:0045778 positive regulation of ossification Added SYNONYM positive regulation of bone formation
2004-01-03 GO:0046013 regulation of T cell homeostatic proliferation Added SYNONYM regulation of resting T-cell proliferation
2004-01-03 GO:0019052 suppression by virus of host intracellular antiviral response Deleted SYNONYM negative regulation by virus of intracellular antiviral response
2004-01-03 GO:0019053 suppression by virus of host extracellular antiviral response Deleted SYNONYM negative regulation by virus of extracellular antiviral response
2004-01-03 GO:0001777 T cell homeostatic proliferation Added SYNONYM resting T-cell proliferation
2004-01-03 GO:0019052 suppression by virus of host intracellular antiviral response Added SYNONYM viral inhibition of intracellular antiviral response
2004-01-03 GO:0019053 suppression by virus of host extracellular antiviral response Added SYNONYM inhibition of extracellular antiviral response
2004-01-03 GO:0046014 negative regulation of T cell homeostatic proliferation Added SYNONYM negative regulation of resting T-cell proliferation
2004-01-03 GO:0050690 regulation of defense response to virus by virus Added SYNONYM viral regulation of antiviral response
2004-01-03 GO:0008261 allatostatin receptor activity Updated DEFINITION Combining with allatostatin to initiate a change in cell activity.
2004-01-03 GO:0016964 alpha-2 macroglobulin receptor activity Updated DEFINITION Combining with an alpha-2 macroglobulin to initiate a change in cell activity.
2004-01-03 GO:0008227 G-protein coupled amine receptor activity Updated DEFINITION Combining with a biogenic amine to initiate a change in cell activity.
2004-01-03 GO:0004942 anaphylatoxin receptor activity Updated DEFINITION Combining with anaphylatoxin to initiate a change in cell activity.
2004-01-03 GO:0004882 androgen receptor activity Updated DEFINITION Combining with an androgen to initiate a change in cell activity.
2004-01-03 GO:0001595 angiotensin receptor activity Updated DEFINITION Combining with angiotensin to initiate a change in cell activity.
2004-01-03 GO:0030895 apolipoprotein B mRNA editing enzyme complex Updated DEFINITION Protein complex that mediates editing of the mRNA encoding apolipoprotein B; catalyzes the deamination of C to U (residue 6666 in the human mRNA). Contains a catalytic subunit, APOBEC-1, and other proteins (e. g. human ASP; rat ASP and KSRP).
2004-01-03 GO:0030227 apolipoprotein E receptor activity Updated DEFINITION Combining with apolipoprotein E to initiate a change in cell activity.
2004-01-03 GO:0030226 apolipoprotein receptor activity Updated DEFINITION Combining with an apolipoprotein, the protein component of a lipoprotein, to initiate a change in cell activity.
2004-01-03 GO:0004874 aryl hydrocarbon receptor activity Updated DEFINITION Combining with an aryl hydrocarbon to initiate a change in cell activity.
2004-01-03 GO:0043057 backward locomotion Updated DEFINITION Posterior movement of an organism, e. g., following the direction of the tail of an animal.
2004-01-03 GO:0008503 benzodiazepine receptor activity Updated DEFINITION Combining with benzodiazepines, a class of drugs with hypnotic, anxiolytic, anticonvulsive, amnestic and myorelaxant properties, to initiate a change in cell activity.
2004-01-03 GO:0004979 beta-endorphin receptor activity Updated DEFINITION Combining with beta-endorphin to initiate a change in cell activity.
2004-01-03 GO:0004946 bombesin receptor activity Updated DEFINITION Combining with bombesin to initiate a change in cell activity.
2004-01-03 GO:0008288 boss receptor activity Updated DEFINITION Combining with the protein bride of sevenless (boss) to initiate a change in cell activity.
2004-01-03 GO:0004947 bradykinin receptor activity Updated DEFINITION Combining with bradykinin to initiate a change in cell activity.
2004-01-03 GO:0016493 C-C chemokine receptor activity Updated DEFINITION Combining with a C-C chemokine to initiate a change in cell activity. C-C chemokines do not have an amino acid between the first two cysteines of the characteristic four-cysteine motif.
2004-01-03 GO:0016494 C-X-C chemokine receptor activity Updated DEFINITION Combining with a C-X-C chemokine to initiate a change in cell activity. A C-X-C chemokine has a single amino acid between the first two cysteines of the characteristic four cysteine motif.
2004-01-03 GO:0016495 C-X3-C chemokine receptor activity Updated DEFINITION Combining with a C-X3-C chemokine to initiate a change in cell activity. A C-X3-C chemokine has three amino acids between the first two cysteines of the characteristic four-cysteine motif.
2004-01-03 GO:0042010 interleukin-15 receptor activity Updated DEFINITION Combining with interleukin-15 to initiate a change in cell activity.
2004-01-03 GO:0042012 interleukin-16 receptor activity Updated DEFINITION Combining with interleukin-16 to initiate a change in cell activity.
2004-01-03 GO:0030368 interleukin-17 receptor activity Updated DEFINITION Combining with interleukin-17 to initiate a change in cell activity.
2004-01-03 GO:0042008 interleukin-18 receptor activity Updated DEFINITION Combining with interleukin-18 to initiate a change in cell activity.
2004-01-03 GO:0042014 interleukin-19 receptor activity Updated DEFINITION Combining with interleukin-19 to initiate a change in cell activity.
2004-01-03 GO:0004911 interleukin-2 receptor activity Updated DEFINITION Combining with interleukin-2 to initiate a change in cell activity.
2004-01-03 GO:0042016 interleukin-20 receptor activity Updated DEFINITION Combining with interleukin-20 to initiate a change in cell activity.
2004-01-03 GO:0001532 interleukin-21 receptor activity Updated DEFINITION Combining with interleukin-21 to initiate a change in cell activity.
2004-01-03 GO:0042018 interleukin-22 receptor activity Updated DEFINITION Combining with interleukin-22 to initiate a change in cell activity.
2004-01-03 GO:0042020 interleukin-23 receptor activity Updated DEFINITION Combining with interleukin-23 to initiate a change in cell activity.
2004-01-03 GO:0045506 interleukin-24 receptor activity Updated DEFINITION Combining with interleukin-24 to initiate a change in cell activity.
2004-01-03 GO:0045507 interleukin-25 receptor activity Updated DEFINITION Combining with interleukin-25 to initiate a change in cell activity.
2004-01-03 GO:0045508 interleukin-26 receptor activity Updated DEFINITION Combining with interleukin-26 to initiate a change in cell activity.
2004-01-03 GO:0045509 interleukin-27 receptor activity Updated DEFINITION Combining with interleukin-27 to initiate a change in cell activity.
2004-01-03 GO:0004985 opioid receptor activity Updated DEFINITION Combining with an opioid, any narcotic derived from or resembling opium, to initiate a change in cell activity.
2004-01-03 GO:0016499 orexin receptor activity Updated DEFINITION Combining with orexin to initiate a change in cell activity.
2004-01-03 GO:0004990 oxytocin receptor activity Updated DEFINITION Combining with oxytocin to initiate a change in cell activity.
2004-01-03 GO:0001602 pancreatic polypeptide receptor activity Updated DEFINITION Combining with pancreatic polypeptide PP to initiate a change in cell activity.
2004-01-03 GO:0001653 peptide receptor activity Updated DEFINITION Combining with an extracellular or intracellular peptide to initiate a change in cell activity.
2004-01-03 GO:0001601 peptide YY receptor activity Updated DEFINITION Combining with gut peptide YY to initiate a change in cell activity.
2004-01-03 GO:0016503 pheromone receptor activity Updated DEFINITION Combining with a pheromone to initiate a change in cell activity.
2004-01-03 GO:0001565 phorbol ester receptor activity Updated DEFINITION Combining with a phorbol ester to initiate a change in cell activity.
2004-01-03 GO:0048170 positive regulation of long-term neuronal synaptic plasticity Updated DEFINITION A process that increases long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
2004-01-03 GO:0048173 positive regulation of short-term neuronal synaptic plasticity Updated DEFINITION A process that increases short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
2004-01-03 GO:0001785 prostaglandin J receptor activity Updated DEFINITION The function of combining with prostaglandin J (PGJ(2)), a metabolite of prostaglandin D (PGD(2)) to initiate a change in cell activity.
2004-01-03 GO:0004872 receptor activity Updated DEFINITION Combining with an extracellular or intracellular messenger to initiate a change in cell activity.
2004-01-03 GO:0015056 corticotrophin-releasing factor receptor activity Updated DEFINITION Combining with the corticotrophin-releasing factor family of ligands, including the urocortins, to initiate a change in cell activity.
2004-01-03 GO:0001631 cysteinyl leukotriene receptor activity Updated DEFINITION Combining with a cysteinyl leukotriene to initiate a change in cell activity. Cysteinyl leukotrienes are leukotrienes that contain a peptide moiety based on cysteine.
2004-01-03 GO:0009884 cytokinin receptor activity Updated DEFINITION Combining with a cytokinin to initiate a change in cell activity.
2004-01-03 GO:0008036 diuretic hormone receptor activity Updated DEFINITION Combining with a diuretic hormone to initiate a change in cell activity.
2004-01-03 GO:0004952 dopamine neurotransmitter receptor activity Updated DEFINITION Combining with the neurotransmitter dopamine to initiate a change in cell activity.
2004-01-03 GO:0042654 ecdysis-triggering hormone receptor activity Updated DEFINITION Combining with ecdysis-triggering hormone to initiate a change in cell activity.
2004-01-03 GO:0004884 ecdysteroid hormone receptor activity Updated DEFINITION Combining with ecdysteroid hormone to initiate a change in cell activity.
2004-01-03 GO:0008529 endogenous peptide receptor activity Updated DEFINITION OBSOLETE. Combining with an intracellular peptide to initiate a change in cell activity.
2004-01-03 GO:0004962 endothelin receptor activity Updated DEFINITION Combining with endothelin to initiate a change in cell activity.
2004-01-03 GO:0004900 erythropoietin receptor activity Updated DEFINITION Combining with erythropoietin to initiate a change in cell activity.
2004-01-03 GO:0030284 estrogen receptor activity Updated DEFINITION Combining with estrogen to initiate a change in cell activity.
2004-01-03 GO:0008530 exogenous peptide receptor activity Updated DEFINITION OBSOLETE. Combining with an extracellular peptide to initiate a change in cell activity.
2004-01-03 GO:0019763 immunoglobulin receptor activity Updated DEFINITION Combining with the Fc region of an immunoglobulin protein to initiate a change in cell activity.
2004-01-03 GO:0004928 frizzled receptor activity Updated DEFINITION OBSOLETE. Combining with a member of the Wnt-family of signaling molecules to initiate a change in cell activity.
2004-01-03 GO:0004929 frizzled-2 receptor activity Updated DEFINITION OBSOLETE. Combining with to a member of the Wnt-family of signaling molecules to initiate a change in cell activity.
2004-01-03 GO:0001647 G-protein coupled cytokinin receptor activity Updated DEFINITION Combining with a cytokinin to initiate a change in cell activity. The receptor is G-protein coupled.
2004-01-03 GO:0016917 GABA receptor activity Updated DEFINITION Combining with the neurotransmitter GABA (gamma aminobutyric acid) to initiate a change in cell activity.
2004-01-03 GO:0004890 GABA-A receptor activity Updated DEFINITION Combining with the neurotransmitter GABA-A (gamma aminobutyric acid) to initiate a change in cell activity.
2004-01-03 GO:0048169 regulation of long-term neuronal synaptic plasticity Updated DEFINITION A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
2004-01-03 GO:0004949 cannabinoid receptor activity Updated DEFINITION Combining with cannabinoids to initiate a change in cell activity.
2004-01-03 GO:0004895 cell adhesion receptor activity Updated DEFINITION Combining with cell adhesion molecules to initiate a change in cell activity.
2004-01-03 GO:0030896 checkpoint clamp complex Updated DEFINITION Conserved heterotrimeric complex of PCNA-like proteins that is loaded onto DNA at sites of DNA damage.
2004-01-03 GO:0004950 chemokine receptor activity Updated DEFINITION Combining with chemokines, small chemoattractant molecules normally used to stimulate leukocytes, to initiate a change in cell activity.
2004-01-03 GO:0004951 cholecystokinin receptor activity Updated DEFINITION Combining with cholecystokinin, a 33-amino acid peptide secreted by the upper intestinal mucosa and also found in the central nervous system, to initiate a change in cell activity.
2004-01-03 GO:0050799 cocaine biosynthetic process Added DEFINITION The formation from simpler components of cocaine, an alkaloid obtained from the dried leaves of the shrub Erythroxylon coca. It is a cerebral stimulant and narcotic.
2004-01-03 GO:0004965 G-protein coupled GABA receptor activity Updated DEFINITION Combining with the neurotransmitter GABA-B (gamma aminobutyric acid) to initiate a change in cell activity.
2004-01-03 GO:0004966 galanin receptor activity Updated DEFINITION Combining with galanin to initiate a change in cell activity.
2004-01-03 GO:0016519 gastric inhibitory peptide receptor activity Updated DEFINITION Combining with gastric inhibitory peptide to initiate a change in cell activity.
2004-01-03 GO:0015054 gastrin receptor activity Updated DEFINITION Combining with gastrin to initiate a change in cell activity.
2004-01-03 GO:0004883 glucocorticoid receptor activity Updated DEFINITION Combining with a glucocorticoid to initiate a change in cell activity.
2004-01-03 GO:0004912 interleukin-3 receptor activity Updated DEFINITION Combining with interleukin-3 to initiate a change in cell activity.
2004-01-03 GO:0004913 interleukin-4 receptor activity Updated DEFINITION Combining with interleukin-4 to initiate a change in cell activity.
2004-01-03 GO:0004914 interleukin-5 receptor activity Updated DEFINITION Combining with interleukin-5 to initiate a change in cell activity.
2004-01-03 GO:0004915 interleukin-6 receptor activity Updated DEFINITION Combining with interleukin-6 to initiate a change in cell activity.
2004-01-03 GO:0004917 interleukin-7 receptor activity Updated DEFINITION Combining with interleukin-7 to initiate a change in cell activity.
2004-01-03 GO:0004918 interleukin-8 receptor activity Updated DEFINITION Combining with interleukin-8 to initiate a change in cell activity.
2004-01-03 GO:0004919 interleukin-9 receptor activity Updated DEFINITION Combining with interleukin-9 to initiate a change in cell activity.
2004-01-03 GO:0004880 juvenile hormone receptor activity Updated DEFINITION Combining with juvenile hormone to initiate a change in cell activity.
2004-01-03 GO:0005055 laminin receptor activity Updated DEFINITION Combining with a laminin, a glycoprotein that constitutes the majority of proteins in the basement membrane, to initiate a change in cell activity.
2004-01-03 GO:0016524 latrotoxin receptor activity Updated DEFINITION Combining with alpha-latrotoxin, a potent presynaptic neurotoxin, to initiate a change in cell activity.
2004-01-03 GO:0001632 leukotriene B4 receptor activity Updated DEFINITION Combining with leukotriene B4, LTB4, to initiate a change in cell activity. Leukotriene B4 is also known as (6Z, 8E, 10E, 14Z)-(5S, 12R)-5,12-dihydroxyicosa-6,8,10,14-tetraen-1-oate.
2004-01-03 GO:0004974 leukotriene receptor activity Updated DEFINITION Combining with a leukotriene to initiate a change in cell activity. Leukotrienes are pharmacologically active substances with a set of three conjugated double bonds; some contain a peptide moiety based on cysteine.
2004-01-03 GO:0030228 lipoprotein particle receptor activity Updated DEFINITION Combining with a lipoprotein to initiate a change in cell activity. A lipoprotein is any conjugated, water-soluble protein in which the nonprotein moiety consists of a lipid or lipids; the lipid may be triacylglycerol, cholesterol, or phospholipid, or a combination of these.
2004-01-03 GO:0005041 low-density lipoprotein receptor activity Updated DEFINITION Combining with a low-density lipoprotein to initiate a change in cell activity.
2004-01-03 GO:0001619 lysosphingolipid and lysophosphatidic acid receptor activity Updated DEFINITION Combining with lysosphingolipid or lysophosphatidic acid to initiate a change in cell activity.
2004-01-03 GO:0005011 macrophage colony-stimulating factor receptor activity Updated DEFINITION Combining with macrophage colony stimulating factor to initiate a change in cell activity.
2004-01-03 GO:0004932 mating-type factor pheromone receptor activity Updated DEFINITION Combining with a mating-type factor pheromone to initiate a change in cell activity.
2004-01-03 GO:0030273 melanin-concentrating hormone receptor activity Updated DEFINITION Combining with the cyclic peptide hormone melanin-concentrating hormone to initiate a change in cell activity.
2004-01-03 GO:0004977 melanocortin receptor activity Updated DEFINITION Combining with melanocortin to initiate a change in cell activity.
2004-01-03 GO:0008502 melatonin receptor activity Updated DEFINITION Combining with melatonin, N-acetyl-5-methoxytryptamine, to initiate a change in cell activity. Melatonin is a neuroendocrine substance that stimulates the aggregation of melanosomes in melanophores, thus lightening the skin.
2004-01-03 GO:0017082 mineralocorticoid receptor activity Updated DEFINITION Combining with mineralocorticoid to initiate a change in cell activity.
2004-01-03 GO:0035013 myosuppressin receptor activity Updated DEFINITION Combining with the peptide myosuppressin to initiate a change in cell activity.
2004-01-03 GO:0004982 N-formyl peptide receptor activity Updated DEFINITION Combining with an N-formyl peptide to initiate a change in cell activity.
2004-01-03 GO:0048171 negative regulation of long-term neuronal synaptic plasticity Updated DEFINITION A process that decreases long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.
2004-01-03 GO:0048174 negative regulation of short-term neuronal synaptic plasticity Updated DEFINITION A process that decreases short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.
2004-01-03 GO:0001607 neuromedin U receptor activity Updated DEFINITION Combining with neuromedin U to initiate a change in cell activity.
2004-01-03 GO:0042263 neuropeptide F receptor activity Updated DEFINITION Combining with neuropeptide F, an invertebrate neuropeptide thought to play a role in neuroregulation, to initiate a change in cell activity. In many species, neuropeptide F is between 36 and 39 amino acid residues terminating in a phenylalaninamide residue.
2004-01-03 GO:0008188 neuropeptide receptor activity Updated DEFINITION Combining with a neuropeptide to initiate a change in cell activity.
2004-01-03 GO:0004983 neuropeptide Y receptor activity Updated DEFINITION Combining with neuropeptide Y to initiate a change in cell activity.
2004-01-03 GO:0030594 neurotransmitter receptor activity Updated DEFINITION Combining with a neurotransmitter to initiate a change in cell activity.
2004-01-03 GO:0005049 nuclear export signal receptor activity Updated DEFINITION Combining with a nuclear export signal to initiate a change in cell activity.
2004-01-03 GO:0016502 nucleotide receptor activity Updated DEFINITION Combining with a nucleotide to initiate a change in cell activity. A nucleotide is a compound that consists of a nucleoside esterified with a phosphate molecule.
2004-01-03 GO:0004989 octopamine receptor activity Updated DEFINITION Combining with the biogenic amine octopamine to initiate a change in cell activity. Octopamine is found in both vertebrates and invertebrates and can have properties both of a hormone and a neurotransmitter and acts as an adrenergic agonist.
2004-01-03 GO:0004984 olfactory receptor activity Updated DEFINITION Combining with airborne compounds to initiate a change in cell activity. These receptors are used for the sense of smell.
2004-01-03 GO:0015464 acetylcholine receptor activity Updated DEFINITION Combining with acetylcholine to initiate a change in cell activity.
2004-01-03 GO:0050798 activated T cell proliferation Added DEFINITION The rapid expansion of a T-cell population following activation by an antigenic stimulus.
2004-01-03 GO:0004978 corticotropin receptor activity Updated DEFINITION Combining with adrenocorticotropin to initiate a change in cell activity.
2004-01-03 GO:0001605 adrenomedullin receptor activity Updated DEFINITION Combining with adrenomedullin to initiate a change in cell activity.
2004-01-03 GO:0050785 advanced glycation end-product receptor activity Updated DEFINITION Combining with advanced glycation end-products to initiate a change in cell activity.
spacer
Please send comments, suggestions or bug reports to goa@ebi.ac.uk. Click here for details of how to cite UniProt-GOA and QuickGO.
127ms